A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
This trial tests a common real-world question: switching from IV induction to subcutaneous vedolizumab maintenance in adults with moderate-to-severe UC or CD and measures short-term remission and longer-term treatment...